This inventor holds 3 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents. Top assignee: Bausch-Lomb Incorporated. Active years: 2009-2012.
Location History:
- Fairport, NY (US) (2009)
- Overland Park, KS (US) (2012)
Company Filing History:
Years Active: 2009-2012
Title: Arthur E. Harms: Innovator in Pharmaceutical Chemistry
Introduction
Arthur E. Harms is a notable inventor based in Overland Park, KS (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of quinolone carboxylic acids and their derivatives. With a total of 3 patents to his name, Harms has demonstrated a commitment to advancing medical science through innovative processes.
Latest Patents
Harms' latest patents focus on the preparation of quinolone carboxylic acids and their derivatives. One of his key inventions involves a process that utilizes a starting quinolone with desired substituents at specific positions on the quinolone ring. This method preserves the orientation of these substituents throughout the synthesis, resulting in a more efficient process with fewer steps than prior-art methods. Additionally, this process allows for the simple separation of a desired enantiomer from an enantiomeric mixture. The pharmaceutical compositions derived from these processes, particularly fluoroquinolones, have shown effectiveness against various microbial pathogens.
Career Highlights
Arthur E. Harms is currently associated with Bausch + Lomb Incorporated, where he continues to apply his expertise in pharmaceutical development. His work has not only contributed to the company's portfolio but has also had a broader impact on the field of medicine.
Collaborations
Throughout his career, Harms has collaborated with talented individuals such as Ramakrishnan Arul and Anil Kumar Soni. These collaborations have fostered an environment of innovation and have led to the successful development of new pharmaceutical solutions.
Conclusion
Arthur E. Harms stands out as a significant figure in the realm of pharmaceutical chemistry. His innovative approaches to the synthesis of quinolone carboxylic acids have the potential to enhance the effectiveness of treatments against microbial pathogens. His contributions continue to shape the future of medical science.